We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BDRX market cap is 2.49M. The company's latest EPS is GBP and P/E is N/A.
Quarter End | |||||
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 674k | 343k | 578k | 699k | 381k |
Operating Income | -12.13M | -23.17M | -7.04M | -8.7M | -7.85M |
Net Income | -10.09M | -22.19M | -5.46M | -7.66M | -7.08M |
Quarter End | |||||
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 30.9M | 9.82M | 12.91M | 5.53M | 10.54M |
Total Liabilities | 11.34M | 3.1M | 2.46M | 2.36M | 5.86M |
Total Equity | 19.56M | 6.72M | 10.45M | 3.16M | 4.68M |
Quarter End | |||||
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | |||||
Investing | |||||
Financing |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -6.49M | -9.3M | -6.01M | -7.05M | -6.83M |
Investing | -3.81M | 2.57M | -278k | -220k | -265k |
Financing | 18.73M | 3.08M | 8.81M | 47k | 10.23M |
Market Cap | 2.49M |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 580.84k |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.12 (2.76%) |
Company Name | Biodexa Pharmaceuticals PLC |
Address |
1 caspian point cardiff CF10 4DQ |
Website | https://www.midatechgroup.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions